Connect Biopharma Holdings Limited (CNTB) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Connect Biopharma Holdings Limited (CNTB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $138.5M, listed on NASDAQ, employing roughly 62 people, carrying a beta of -0.20 to the broader market. Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. Led by Barry D. Quart, public since 2021-03-19.
Snapshot as of May 15, 2026.
- Spot Price
- $2.39
- Total OI
- 4.3K